Market research
CRY GraniteShares YieldBOOST CRCL ETF
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 703M
- P/E ratio
- 425.71
- Analyst target
- 32.44
- Dividend yield
- 0.2%
- Beta
- 0.0
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- ISIN
- US2289031005
- Market cap
- 703M
- P/E ratio
- 425.71
- Analyst target
- 32.44
- Dividend yield
- 0.2%
- Beta
- 0.0
About
About GraniteShares YieldBOOST CRCL ETF
The fund will invest at least 80% of its net assets in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. It is non-diversified.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CRY discussion.
5 years, 4 months ago
CryoLife, Inc is currently in a long term uptrend where the price is trading 15.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
CryoLife, Inc's total revenue sank by 2.6% to $68M since the same quarter in the previous year.
Its net income has dropped by 407.8% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 284.0% to $3M since the same quarter in the previous year.
Based on the above factors, CryoLife, Inc gets an overall score of 3/5.